In episode 241, Mike and James decide to delve into the impact industry marketing has on how and why we prescribe. We start off by discussing the theoretical issues surrounding the marketing of medications and briefly touch on the ethical dilemmas. At the end we realize we really haven’t discussed any evidence other than our own personal opinion and so we make a pact to discuss the evidence around this area in the next podcast.
Show notes
1) Industry and us
In episode 240, Mike and James target the information around hitting guideline targets. We talk about the futility of trying to get patients to all the thresholds and we end with discussing the problem of collateral damage when we all shoot for these targets.
Show notes
1) Tools For Practice
In episode 239, James, Mike and Adrienne get down and personal with the evidence around testosterone replacement. We find out very quickly that the data suffers from inconsistent results, small sample size, poor method description, lack of validated/useful endpoints, funding bias, and multiple outcome reporting – but other than that it is solid and all the answers are clear.
Show notes
1) Tools For Practice
Testosterone supplementation in men: Let’s pause for a moment
THE NUTRITION PROPOSITION BOOK
Check it out at nutritionproposition.com and think about picking up a copy on Amazon. All the evidence you ever wanted about nutrition and the only nutrition book that won’t tell you what to eat.
